Clinical studies recruiting near Avellino

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Azienda Ospedaliera San Giuseppe Moscati · Pfizer · NCT06758401 Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Phase 3 · AO "San Giuseppe Moscati" - UOC Ematologia con unità di trap · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04168502 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · AO Moscati · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Ly
Phase N/A · Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e T · Fondazione Italiana Linfomi - ETS · NCT06008691 Tensi+ European Registry
Phase N/A · Nuova Villa Esther · Stimuli Technology · NCT07205445 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer
Phase 3 · AORN S. Giuseppe Moscati · University of Campania Luigi Vanvitelli · NCT07389265 Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Phase N/A · A.O.S.G. Moscati · Azienda USL Reggio Emilia - IRCCS · NCT06822855 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · AORN San Giuseppe Moscati Avellino - U.O.C. Oncologia Medica · Bayer · NCT06452277 The ONCOCAMP Study
Phase N/A · A.O. Moscati · National Cancer Institute, Naples · NCT06270602 Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO
Phase 3 · AORN San Giuseppe Moscati Avellino, U.O.C. Ematologia e Trap · Fondazione Italiana Linfomi - ETS · NCT05929222 GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in th
Phase N/A · AORN S.G. Moscati · Fondazione Oncotech · NCT07583485 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · Azienda Ospedaliera San Giuseppe Moscati · BioNTech SE · NCT06712316 A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat
Phase 2/Phase 3 · Local Institution - 0609 · Bristol-Myers Squibb · NCT07221357 Tickle Stimulation in Disorders of Consciousness (DoC)
Phase N/A · Anna Estraneo · NCT06922162 Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for
NA · San Giuseppe Moscati Hospital · S&R Farmaceutici S.p.A. · NCT07685847 heaRtInsiGHT Alert guIDE: RightAIDE Application of the HeartInsight Acute Heart Failure Predictor in Routine Clinical Pr
Phase N/A · University of Padova · NCT07281859 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · Azienda Ospedaliera San Giuseppe Moscati · BioNTech SE · NCT06712355 ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
Phase 2 · AORN San Giuseppe Moscati Avellino · National Cancer Institute, Naples · NCT06714357 Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
Phase 2 · Azienda Ospedaliera S.Giuseppe Moscati, S.C. Ematologia e Tr · Fondazione Italiana Linfomi - ETS · NCT06492837 Continuous Glucose Monitoring in HIE
NA · A.O.S.G. Moscati · University of Campania Luigi Vanvitelli · NCT06563687 A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Ho
Phase 2 · Azienda Ospedaliera S. Giuseppe Moscati - S.C. Ematologia e · Fondazione Italiana Linfomi - ETS · NCT06835530 Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Phase N/A · AORN San Giuseppe Moscati Avellino · Manuel Monreal · NCT02832245 REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07229235 A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-Wor
Phase N/A · Ospedale San Giuseppe Moscati di Avellino · Janssen Research & Development, LLC · NCT07230691 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colo
Phase 3 · UOC Oncologia Medica - Dipartimento Onco Ematologico AORN Sa · Seagen, a wholly owned subsidiary of Pfizer · NCT05253651 BRCA Mutation Carriers' Platform a Multicenter Study
Phase N/A · Malzoni Research Hospital · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07253051 Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Phase N/A · Malzoni - Avellino · Azienda USL Reggio Emilia - IRCCS · NCT06749600 Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant t
Phase 2 · A.O. S. Giuseppe Moscati · Associazione Qol-one · NCT05924100 Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Phase 1/Phase 2 · S.C. Ematologia e Trapianto emopoietico - Azienda Ospedalier · Fondazione Italiana Linfomi - ETS · NCT05300282

Look up another city

Look up another condition